Aspen Pharmacare HL-Unsp ADRAPNHY
13F holders, Q4 2024 (December 31)1holders
0new positions
0sold out
$8.26avg. 13F price*
At the end of Q4 2024, 1 institutions reported holding Aspen Pharmacare HL-Unsp ADR (APNHY) in their 13F filings, unchanged from Q3 2024. 0 opened new positions and 0 sold out. The largest holder was Rhumbline Advisers ($5K).
- Company
- Aspen Pharmacare HL-Unsp ADR
- CUSIP
- 04530Y106
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q3 2024 → Q4 2024: 205 shares bought, net +205 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Rhumbline Advisers | 0.00% | Add +50.6% | 610 | $5K |
"% of holder's portfolio" is APNHY's weight in each manager's 13F, not the share of Aspen Pharmacare HL-Unsp ADR the manager owns.